JNJ — Johnson & Johnson
$285.75
+$2.23 (+0.79%)
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech.
Market Cap
$687.89B
Forward P/E
24.6x
52-Week Range
JNJ Price History
Current price
$269.12
JNJ return (1Y)
+51.1%
S&P 500 return (1Y)
+18.1%
vs S&P 500
+32.9 pts
Revenue vs. Net Income
$94.2B
Revenue · FY2025
Annual. Net margin is shown under each year.
Free Cash Flow
$19.3B
FCF · FY2025
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
23.1%
ROCE · FY2025
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
1.7x
Assets ÷ liabilities · FY2025
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
5.5%
CapEx · FY2025
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
+0.0%
Net buyback · FY2025
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
